TAKE Solutions Launches AI-Driven 'Take.Health' Platform

TAKE Solutions officially launched its new AI-driven digital health platform, 'Take.Health', on March 25, 2026. The platform focuses on preventive care and personalized user insights, aiming to capture a significant share of India's rapidly growing preventive healthcare market, which is projected to exceed $197 billion by 2030.

This move enters a vast Indian healthcare sector, currently valued around $370 billion in 2024, signalling a major opportunity for AI and digital solutions. The 'Take.Health' platform is designed to build scalable, recurring revenue streams.

Strategic Shift and Revenue Goals

This launch represents a significant strategic pivot for TAKE Solutions, placing it directly into the fast-growing AI-powered prevention and personalized wellness market. The company aims to generate new revenue through subscription-based services and data insights, moving away from its previous business models.

The initiative is designed to leverage the intersection of healthcare, data analytics, and technology, tapping into India's widespread digital adoption. With over 600 million smartphone users, the government's focus on AI for public benefit creates a favorable environment for such platforms.

Company History and Pivot

Founded in 2000, TAKE Solutions previously focused on Life Sciences and Supply Chain Management (SCM) services, operating on a model that offered both services and intellectual property. Its historical offerings included clinical, regulatory, and safety services.

Recent years saw the company undergo substantial restructuring and divestments, notably selling off Navitas Life Sciences and Ecron Acunova. While these moves reduced its operational scale and revenue, they resulted in a debt-free financial position and a reduced operational footprint.

TAKE Solutions has since shifted its focus to become an AI-driven healthcare technology firm, emphasizing preventive diagnostics and personalized care. Its stock has seen speculative trading linked to this new direction. The company also plans to use Anthropic's Claude AI to enhance its new platforms.

Potential Risks

Key challenges for AI adoption in Indian healthcare include the potential for a widening digital divide, which could exclude rural and underserved communities. AI models trained on limited data may also exhibit biases, leading to inaccurate diagnoses and exacerbating existing health inequities.

Many AI healthcare tools lack extensive real-world clinical validation, raising questions about their reliability and scalability. Additionally, the ethical handling and privacy of sensitive health data pose significant concerns.

TAKE Solutions' past financial difficulties, including loan defaults, led to a considerable reduction in its operations. The company's current stock performance is considered speculative, highly dependent on the successful execution of its AI health strategy. Regulatory approval for imported AI diagnostic tools that might be integrated into its new initiatives also presents a potential hurdle.

Competitive Landscape

TAKE Solutions is entering a competitive Indian market where several companies are already utilizing AI in healthcare. Competitors include:

• Qure.ai, which uses AI for medical image analysis to assist in diagnostics.
• SigTuple, employing machine learning for analyzing medical data such as blood and urine samples.
• Innovaccer, offering AI and cloud-based platforms for health data analytics to improve patient outcomes.
• Niramai, specializing in AI-driven, non-invasive breast cancer screening.

These examples show a dynamic market with varied AI applications across diagnostics, data analysis, and specialized medical screening.

Key Market Figures

The Indian healthcare market was valued at approximately $370 billion in 2024.
India's preventive healthcare sector is projected to grow beyond $197 billion by 2030.
The nation's digital health market, valued at $8.79 billion in 2024, is expected to reach $47.80 billion by 2033.

What to Watch Next

Investors and observers will be monitoring the adoption and user engagement levels for the 'Take.Health' platform.
Key metrics to track include revenue generation and the successful establishment of scalable, recurring income streams.
Progress in integrating AI capabilities and data analytics, alongside the platform's effectiveness in meeting preventive and personalized healthcare needs, will be important.
Any regulatory developments, approvals, or challenges concerning AI-driven health technologies should also be closely watched.